QuickView for Tumour necrosis factor, conserved site (biogroup)

1. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
2. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
3. Neuronal cells PSA-NCAM+ trans-differentiated from peripheral blood mononuclear cells
4. L1000 CMAP - Non-small cell lung cancer A549.311 cells with CRISPR targeted gene knockouts
5. L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens

There were no matches for Tumour necrosis factor, conserved site

1. Comparison Between Surgery and Radiofrequency for Treatment of Renal Tumors
2. Randomized Study of Combination Chemotherapy With or Without Focused Microwave Thermotherapy Before …
3. Circulating Tumor DNA Enriched, Genomically Directed Post-neoadjuvant Trial for Patients With Residu…
4. Cancer Vaccine Targeting Brachyury Protein in Tumors
5. Effect of Pulsed Mode Radiofrequency as a Treatment of Lumbar Disc Related Radicular Pain on Tumor N…